Ryman Healthcare Ltd
F:RH70
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ryman Healthcare Ltd
F:RH70
|
NZ |
|
Thales SA
PAR:HO
|
FR |
|
D
|
DigitalOcean Holdings Inc
XMUN:0SU
|
US |
|
S
|
Siamese Asset PCL
SET:SA
|
TH |
|
Repsol SA
MAD:REP
|
ES |
|
S
|
Standard Chartered PLC
F:STD
|
UK |
|
Abivax SA
NASDAQ:ABVX
|
FR |
|
Oversea-Chinese Banking Corporation Ltd
F:OCBB
|
SG |
|
K
|
Kulicke and Soffa Industries Inc
XMUN:KU1
|
SG |
Intrinsic Value
Is RH70 undervalued or overvalued?
See the intrinsic value estimate for 
Ryman Healthcare Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
RH70 looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with RH70’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Ryman Healthcare Does
Ryman Healthcare builds, owns, and runs retirement villages and aged-care homes for older adults, mainly in New Zealand and Australia. It offers independent living units, serviced apartments, and care beds, so residents can move from lighter support to more intensive care within the same community as their needs change.
- Headquarters
- New Zealand NZ
- Employees
- 7 800
- IPO date
- Jun 25, 1999
Ryman Healthcare has no economic moat
Ryman Healthcare Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Earnings Waterfall
Ryman Healthcare Ltd
The intrinsic value for Ryman Healthcare Ltd (RH70) under the Base Case is hidden EUR.
Compared with the current market price of 4.1 EUR, the stock appears hidden.